Guest guest Posted February 14, 2011 Report Share Posted February 14, 2011 A study at the University of Michigan published in Clinical Cancer Research Feb 9th, 2011 has a finding of a high-level insulin receptor (INSR) expression in the majority of CLL with del11q. quote: " High INSR mRNA expression in 11q CLL (~10-fold higher mean levels than other genomic categories) was confirmed by Q-PCR in 247 CLL cases. " " Higher INSR levels correlated with shorter time to first therapy (TTFT) and shorter overall survival (OS). In bivariate analysis, INSR expression predicted for rapid initial disease progression and shorter OS in ZAP-70 low/negative CLL. Finally, in multivariate analysis (ZAP-70 status, IgVH status and INSR expression), we detected elevated hazard ratios and trends for short OS for CLL cases with high INSR expression (analyzed inclusive or exclusive of cases with del11q). " " Our aggregate biochemical and clinical outcome data suggest biologically meaningful elevated INSR expression in a substantial subset of all CLL cases, including many cases with del11q. " end quote: Full Paper http://clincancerres.aacrjournals.org/content/early/2011/02/09/1078-0432.CCR-10-\ 2058.long Clearly the 11q story is not over... ~chris Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.